KP Tissue Inc. (TSE:KPT – Free Report) – Analysts at Desjardins increased their Q3 2025 earnings per share (EPS) estimates for KP Tissue in a report issued on Wednesday, May 14th. Desjardins analyst F. Tremblay now expects that the company will post earnings per share of $0.13 for the quarter, up from their previous forecast of $0.10. Desjardins has a “Hold” rating and a $8.50 price objective on the stock. The consensus estimate for KP Tissue’s current full-year earnings is $0.44 per share. Desjardins also issued estimates for KP Tissue’s Q4 2025 earnings at $0.13 EPS and FY2026 earnings at $0.67 EPS.
Separately, TD Securities dropped their price objective on KP Tissue from C$8.50 to C$8.00 and set a “hold” rating for the company in a research note on Thursday, April 17th.
KP Tissue Trading Up 1.9%
Shares of TSE KPT opened at C$8.79 on Friday. KP Tissue has a twelve month low of C$7.54 and a twelve month high of C$8.80. The stock has a fifty day simple moving average of C$8.05 and a 200-day simple moving average of C$8.10. The stock has a market capitalization of C$87.85 million, a PE ratio of 13.76, a PEG ratio of -0.88 and a beta of 0.37.
About KP Tissue
KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins.
Featured Stories
- Five stocks we like better than KP Tissue
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Top 4 ETFs for China Exposure After Tariff Relief
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Build a Complete Bond Portfolio With These 4 ETFs
- Financial Services Stocks Investing
- MarketBeat Week in Review – 05/12 – 05/16
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.